Abstract
Early administration of topical 1% propranolol in superficial hemangioma is often effective in blocking growth and leads to improvement in about 80% of cases (2). However, as for oral treatment the most important side effect of topical therapy is the rebound of hemangioma when topical propranolol is withdrawn. The rebound phenomenon was more common in the past when the hemangioma therapy with beta-blockers was continued for 4-5 months similarly to what was usually done in pre-beta-blocker therapy with corticosteroids. When beta-blocker treatment was prolonged up to the year of life or at least 7 months the rebound incidence decreased significantly. The current case confirms the need to continue topical therapy with beta-blockers throughout the growth period of hemangioma, which is very variable from case to case.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
